Home Biosimilar Antibodies Immunology & Inflammation CD markers Blinatumomab (Anti-CD3 & CD19) For research use only.
Not for use in humans.

Blinatumomab (Anti-CD3 & CD19)

Synonyms: Anti-CD3 & CD19

Blinatumomab (Anti-CD3 & CD19) is a BiTE-class (bi-specific T-cell engager) constructed monoclonal antibody with unique anti-tumor efficacy. Blinatumomab enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts.

Blinatumomab (Anti-CD3 & CD19)

Purity & Quality Control

Batch: A317501 Purity: 99% Protein concentration: 3.49mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Blinatumomab (Anti-CD3 & CD19) is a BiTE-class (bi-specific T-cell engager) constructed monoclonal antibody with unique anti-tumor efficacy. Blinatumomab enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts.

Product Details

CAS No. 853426-35-4
Application Blinatumomab (Anti-CD3 & CD19)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Blinatumomab (Anti-CD3 & CD19) | Blinatumomab (Anti-CD3 & CD19) supplier | purchase Blinatumomab (Anti-CD3 & CD19) | Blinatumomab (Anti-CD3 & CD19) cost | Blinatumomab (Anti-CD3 & CD19) manufacturer | order Blinatumomab (Anti-CD3 & CD19) | Blinatumomab (Anti-CD3 & CD19) distributor